Increased Caspase 3 and Bax Immunoreactivity Accompany Nuclear GAPDH Translocation and Neuronal Apoptosis in Parkinson's Disease
- 1 November 2000
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 166 (1) , 29-43
- https://doi.org/10.1006/exnr.2000.7489
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Involvement of Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) and p53 in Neuronal Apoptosis: Evidence That GAPDH Is Upregulated by p53Journal of Neuroscience, 1999
- Bax, but not Bcl-x L , decreases the lifetime of planar phospholipid bilayer membranes at subnanomolar concentrationsProceedings of the National Academy of Sciences, 1999
- An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegenerationBrain Research Reviews, 1998
- P53 Is Essential for Developmental Neuron Death as Regulated by the TrkA and p75 Neurotrophin ReceptorsThe Journal of cell biology, 1998
- Ectopic Cell Cycle Proteins Predict the Sites of Neuronal Cell Death in Alzheimer’s Disease BrainJournal of Neuroscience, 1998
- Glial pathology but absence of apoptotic nigral neurons in long‐standing Parkinson's diseaseMovement Disorders, 1998
- DNA damage and apoptosis in Alzheimer's disease: colocalization with c- Jun immunoreactivity, relationship to brain area, and effect of postmortem delayJournal of Neuroscience, 1996
- Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentationBiochemical Journal, 1992
- Human mitochondrial complex I dysfunctionBiochimica et Biophysica Acta (BBA) - Bioenergetics, 1992
- Postmortem stability of DNAForensic Science International, 1988